Literature DB >> 24966375

RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment.

Nicola Origlia1, Chiara Criscuolo2, Ottavio Arancio3, Shirley ShiDu Yan4, Luciano Domenici5.   

Abstract

Ischemia is known to increase the deleterious effect of β-amyloid (Aβ), contributing to early cognitive impairment in Alzheimer's disease. Here, we investigated whether transient ischemia may function as a trigger for Aβ-dependent synaptic impairment in the entorhinal cortex (EC), acting through specific cellular signaling. We found that synaptic depression induced by oxygen glucose deprivation (OGD) was enhanced in EC slices either in presence of synthetic oligomeric Aβ or in slices from mutant human amyloid precursor protein transgenic mice (mhAPP J20). OGD-induced synaptic depression was ameliorated by functional suppression of RAGE. In particular, overexpression of the dominant-negative form of RAGE targeted to microglia (DNMSR) protects against OGD-induced synaptic impairment in an amyloid-enriched environment, reducing the activation of stress-related kinases (p38MAPK and JNK) and the release of IL-1β. Our results demonstrate a prominent role for the RAGE-dependent neuroinflammatory pathway in the synaptic failure induced by Aβ and triggered by transient ischemia.
Copyright © 2014 the authors 0270-6474/14/348749-12$15.00/0.

Entities:  

Keywords:  entorhinal cortex; interleukin1-beta; jnk; neuroinflammation; p38mapk; synaptic transmission

Mesh:

Substances:

Year:  2014        PMID: 24966375      PMCID: PMC4069353          DOI: 10.1523/JNEUROSCI.0141-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  84 in total

Review 1.  Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region.

Authors:  M P Witter; H J Groenewegen; F H Lopes da Silva; A H Lohman
Journal:  Prog Neurobiol       Date:  1989       Impact factor: 11.685

2.  Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

Authors:  Nicola Origlia; Massimo Righi; Simona Capsoni; Antonino Cattaneo; Fang Fang; David M Stern; John Xi Chen; Ann Marie Schmidt; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

3.  A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays.

Authors:  Emese Mozes; Akos Hunya; Aniko Posa; Botond Penke; Zsolt Datki
Journal:  Brain Res Bull       Date:  2012-02-25       Impact factor: 4.077

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease.

Authors:  S Du Yan; H Zhu; J Fu; S F Yan; A Roher; W W Tourtellotte; T Rajavashisth; X Chen; G C Godman; D Stern; A M Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

Authors:  Xian Zhang; Kun Zhou; Ruishan Wang; Jiankun Cui; Stuart A Lipton; Francesca-Fang Liao; Huaxi Xu; Yun-wu Zhang
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

8.  A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.

Authors:  Marie P Fogarty; Eric J Downer; Veronica Campbell
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats.

Authors:  Dong-Xu Zhai; Qing-Fei Kong; Wang-Shu Xu; Sha-Sha Bai; Hai-Sheng Peng; Kai Zhao; Guo-Zhong Li; Dan-Dan Wang; Bo Sun; Jing-Hua Wang; Guang-You Wang; Hu-Lun Li
Journal:  Neurosci Lett       Date:  2008-09-02       Impact factor: 3.046

10.  Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats.

Authors:  Jared Clarke; Anders Thornell; Dale Corbett; Hilkka Soininen; Mikko Hiltunen; Jukka Jolkkonen
Journal:  Eur J Neurosci       Date:  2007-10       Impact factor: 3.386

View more
  23 in total

1.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.

Authors:  Douglas Walker; Lih Fen Lue; Gaurav Paul; Amar Patel; Marwan N Sabbagh
Journal:  Expert Opin Investig Drugs       Date:  2015-01-14       Impact factor: 6.206

3.  RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.

Authors:  Fang Fang; Qing Yu; Ottavio Arancio; Doris Chen; Smruti S Gore; Shirley ShiDu Yan; Shi Fang Yan
Journal:  Hum Mol Genet       Date:  2018-03-15       Impact factor: 6.150

Review 4.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

5.  Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.

Authors:  Du Fang; Yongfu Wang; Zhihua Zhang; Heng Du; Shiqiang Yan; Qinru Sun; Changjia Zhong; Long Wu; Jhansi Rani Vangavaragu; Shijun Yan; Gang Hu; Lan Guo; Molly Rabinowitz; Elzbieta Glaser; Ottavio Arancio; Alexander A Sosunov; Guy M McKhann; John Xi Chen; Shirley ShiDu Yan
Journal:  Hum Mol Genet       Date:  2015-06-29       Impact factor: 6.150

6.  Ghrelin ameliorates nerve growth factor Dysmetabolism and inflammation in STZ-induced diabetic rats.

Authors:  Yuxing Zhao; Zhaoxing Shen; Dongling Zhang; Huiqiong Luo; Jinliang Chen; Yue Sun; Qian Xiao
Journal:  Metab Brain Dis       Date:  2017-03-30       Impact factor: 3.584

Review 7.  Mitochondrial Perturbation in Alzheimer's Disease and Diabetes.

Authors:  F Akhter; D Chen; S F Yan; S S Yan
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-04       Impact factor: 3.622

Review 8.  Synaptic therapy in Alzheimer's disease: a CREB-centric approach.

Authors:  Andrew F Teich; Russell E Nicholls; Daniela Puzzo; Jole Fiorito; Rosa Purgatorio; Mauro Fa'; Ottavio Arancio
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

9.  An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's disease.

Authors:  Grazia Rutigliano; Martina Stazi; Ottavio Arancio; D Martin Watterson; Nicola Origlia
Journal:  Neurobiol Aging       Date:  2018-06-12       Impact factor: 4.673

10.  Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.

Authors:  Julia Derk; Keria Bermudez Hernandez; Moises Rodriguez; Meilun He; Hyunwook Koh; Andisheh Abedini; Huilin Li; David Fenyö; Ann Marie Schmidt
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.